Researchers at GlaxoSmithKline and their collaborators have demonstrated a method for suggesting alternative indications for existing drugs that uses data from genome wide association studies and a repository of drug information.
Canada's Prevention of Organ Failure Centre of Excellence in Vancouver is using C$1.5 million (US$1.5 million) in funding from Genome British Columbia and other groups to develop a molecular test intended to personalize treatment for chronic obstructive pulmonary disease.
By Adam Bonislawski
University of North Carolina researchers have developed a chemical proteomics approach to measure global kinase activity and used it to investigate drug resistance in triple-negative breast cancer.
By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Epistem today announced a research collaboration with GlaxoSmithKline to use its amplification technology to gain a better understanding of fibrosis.
CLC Bio said this week that it will provide bioinformatics capabilities for a €12 million ($15 million) five-year project funded by the European Commission's Seventh Framework Program that will study mechanisms involved in stem cell differentiation.